These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9277127)

  • 1. A computational procedure for predicting excipient effects on protein-protein affinities.
    Dignon GL; Dill KA
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highlighting the need for each excipient to appear under a unique name in all products that contain it to guarantee its identification.
    Caballero ML; Quirce S
    J Investig Allergol Clin Immunol; 2023 Dec; ():0. PubMed ID: 38085527
    [No Abstract]   [Full Text] [Related]  

  • 3. Compendium of excipients for parenteral formulations.
    Powell MF; Nguyen T; Baloian L
    PDA J Pharm Sci Technol; 1998; 52(5):238-311. PubMed ID: 9846074
    [No Abstract]   [Full Text] [Related]  

  • 4. A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations.
    Ghosh I; Gutka H; Krause ME; Clemens R; Kashi RS
    MAbs; 2023; 15(1):2205540. PubMed ID: 37243580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Protein Particle Formation in IgG1 mAbs Formulated with PS20 Vs. PS80 When Subjected to Interfacial Dilatational Stress.
    Vaclaw C; Merritt K; Griffin VP; Whitaker N; Gokhale M; Volkin DB; Ogunyankin MO; Dhar P
    AAPS PharmSciTech; 2023 Apr; 24(5):104. PubMed ID: 37081185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Substance Registration System: consistent scientific descriptions for substances related to health.
    Peryea T; Southall N; Miller M; Katzel D; Anderson N; Neyra J; Stemann S; Nguyễn ÐT; Amugoda D; Newatia A; Ghazzaoui R; Johanson E; Diederik H; Callahan L; Switzer F
    Nucleic Acids Res; 2021 Jan; 49(D1):D1179-D1185. PubMed ID: 33137173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Formulation Factors and Oxygen Levels on the Stability of Aqueous Injectable Solution Containing Pemetrexed.
    Won DH; Park H; Ha ES; Kim YM; Hwang HD; Jang SW; Kim MS
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31935808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of Polyphenols from Grape Pomace Using Polyethylene Glycol (PEG)-Grafted Silica Particles and PEG-Assisted Cosolvent Elution.
    Seker A; Arslan B; Chen S
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31212800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.
    Singh SM; Bandi S; Jones DNM; Mallela KMG
    J Pharm Sci; 2017 Dec; 106(12):3486-3498. PubMed ID: 28843351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Protein-Excipient Interaction Hotspots Using Computational Approaches.
    Barata TS; Zhang C; Dalby PA; Brocchini S; Zloh M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27258262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of formulation on the stability and aerosol performance of a nebulized antibody.
    Respaud R; Marchand D; Parent C; Pelat T; Thullier P; Tournamille JF; Viaud-Massuard MC; Diot P; Si-Tahar M; Vecellio L; Heuzé-Vourc'h N
    MAbs; 2014; 6(5):1347-55. PubMed ID: 25517319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein particulate detection issues in biotherapeutics development--current status.
    Das TK
    AAPS PharmSciTech; 2012 Jun; 13(2):732-46. PubMed ID: 22566174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of pharmaceutically equivalent parenteral depot suspension of methyl prednisolone acetate.
    Alam A; Ahuja A; Baboota S; Gidwani SK; Ali J
    Indian J Pharm Sci; 2009 Jan; 71(1):30-4. PubMed ID: 20177452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethyleneglycol) 500 dimethylether as novel solvent for injectable in situ forming depots.
    Schoenhammer K; Petersen H; Guethlein F; Goepferich A
    Pharm Res; 2009 Dec; 26(12):2568-77. PubMed ID: 19795192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative kinetic study of polysorbate autoxidation: the role of unsaturated fatty acid ester substituents.
    Yao J; Dokuru DK; Noestheden M; Park SS; Kerwin BA; Jona J; Ostovic D; Reid DL
    Pharm Res; 2009 Oct; 26(10):2303-13. PubMed ID: 19669100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput combinatorial approach for the discovery of a cremophor EL-free paclitaxel formulation.
    Chen H; Zhang Z; McNulty C; Olbert C; Yoon HJ; Lee JW; Kim SC; Seo MH; Oh HS; Lemmo AV; Ellis SJ; Heimlich K
    Pharm Res; 2003 Aug; 20(8):1302-8. PubMed ID: 12948029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of sucrose esters as alternative surfactants in microencapsulation of proteins by the solvent evaporation method.
    Youan BB; Hussain A; Nguyen NT
    AAPS PharmSci; 2003; 5(2):E22. PubMed ID: 12866947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excipients and their use in injectable products.
    Nema S; Washkuhn RJ; Brendel RJ
    PDA J Pharm Sci Technol; 1997; 51(4):166-71. PubMed ID: 9277127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excipient-drug interactions in parenteral formulations.
    Akers MJ
    J Pharm Sci; 2002 Nov; 91(11):2283-300. PubMed ID: 12379914
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.